Curi RMB Capital’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$766K Sell
73,472
-1,992
-3% -$22.2K 0.01% 504
2026
Q1
$898K Buy
+75,464
New +$772K 0.02% 461
2021
Q1
Sell
-105,394
Closed -$3.96M 456
2020
Q4
$3.96M Sell
105,394
-95,583
-48% -$2.96M 0.14% 147
2020
Q3
$4.38M Sell
200,977
-42,795
-18% -$898K 0.19% 121
2020
Q2
$3.92M Buy
243,772
+29,181
+14% +$488K 0.17% 127
2020
Q1
$3.43M Buy
214,591
+49
+0% +$692 0.16% 138
2019
Q4
$2.36M Buy
214,542
+189,542
+758% +$1.88M 0.07% 252
2019
Q3
$254K Buy
+25,000
New +$255K 0.01% 619

Other funds holding AHCO

Curi RMB Capital's AHCO Position: Q2 2026 in Review

Curi RMB Capital reduced its AdaptHealth (AHCO) stake by 2.6% in Q2 2026, selling an estimated $22.2K and leaving 73,472 shares worth $766K. The position accounts for 0.01% of the portfolio, ranked #504.

Curi RMB Capital first reported a position in AHCO in Q3 2019 and has held it in 8 quarters since. The position peaked at $4.38M in Q3 2020. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Curi RMB Capital held 73,472 shares of AdaptHealth worth $766K as of Q2 2026.
  • Curi RMB Capital sold 1,992 AdaptHealth shares in Q2 2026, an estimated $22.2K.
  • AdaptHealth made up 0.01% of Curi RMB Capital's portfolio in Q2 2026, its #504 holding.
  • Curi RMB Capital first reported a position in AdaptHealth in Q3 2019 and has held it in 8 quarters since.
  • Curi RMB Capital's AdaptHealth position peaked at $4.38M in Q3 2020.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.